BIIB
36
3
MAS
56
2
JCI
55
11
JNPR
63
4
DHR
43
5
NWL
35
4
MO
65
3
CLX
55
3
AA
18
3
WM
74
6
PX
46
3
SE
61
4
WMT
66
4
IR
57
17
CME
56
14
EW
27
5
PBI
42
2
BLK
55
6
MET
56
2
VLO
29
4
BIIB
36
3
MAS
56
2
JCI
55
11
JNPR
63
4
DHR
43
5
NWL
35
4
MO
65
3
CLX
55
3
AA
18
3
WM
74
6
PX
46
3
SE
61
4
WMT
66
4
IR
57
17
CME
56
14
EW
27
5
PBI
42
2
BLK
55
6
MET
56
2
VLO
29
4
Financhill
Back

Verrica Pharmaceuticals Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
29

VRCA
Verrica Pharmaceuticals

Last Price:
$0.48
Seasonality Move:
-11.93%
Buy
52

SRPT
Sarepta Therapeutics

Last Price:
$51.00
Seasonality Move:
12.51%
Sell
29
Verrica Pharmaceuticals (VRCA) is a Sell

Is Verrica Pharmaceuticals a Buy, Sell or Hold?

  • The current Verrica Pharmaceuticals [VRCA] share price is $0.48. The Score for VRCA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $51.03. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VRCA Stock Price Chart

What is Verrica Pharmaceuticals's stock price today?

  • The Verrica Pharmaceuticals share price today is $0.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $51.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

VRCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 45.48 Sell
Chaikin Money Flow: 185445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.45 - 0.61) Sell
Bollinger Bands (100): (0.53 - 0.89) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.25 Sell
Relative Strength Index (14 RSI): 26.54 Sell
Chaikin Money Flow: 1747021 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.57 - 90.55) Sell
Bollinger Bands (100): (83.88 - 128.16) Sell

VRCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.5 Sell
20-day SMA: 0.51 Sell
50-day SMA: 0.6 Sell
200-day SMA: 2.21 Sell
8-day EMA: 0.49 Sell
20-day EMA: 0.52 Sell
50-day EMA: 0.61 Sell
200-day EMA: 1.98 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.28 Sell
20-day SMA: 66.37 Sell
50-day SMA: 91.18 Sell
200-day SMA: 120.65 Sell
8-day EMA: 55.11 Sell
20-day EMA: 66.27 Sell
50-day EMA: 84.86 Sell
200-day EMA: 110.43 Sell

Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.12 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $4.38 per share, and an increase next year of $5.87 per share.

Verrica Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):